IMA: the cash flow

MyFinsight

For the year ending 2025-12-31, IMA had $82,414K increase in cash & cash equivalents over the period.

Cash Flow	2025-12-31
Net loss	-45,349
Depreciation and amortization	399
Non-cash interest expense	489
Stock-based compensation expense	15,391
Accretion/amortization of premium/discount of available-for-sale securities	71
Amortization of right of use-assets	634
Gain on early extinguishment of lease liability	149
Loss on disposal of property and equipment	0
Non-cash research and development expenses for the common stock issuable pursuant to hutchmed agreement	0
Prepaid expenses and other current assets	3,957
Other non-current assets	1,205
Accounts payable	-2,820
Accrued expenses and other current liabilities	-9,097
Deferred revenue	-650
Operating lease liabilities	-1,238
Other long-term liabilities	-221
Net cash used in operating activities	-47,844
Cash divested in non-ox40 divestiture	5,215
Proceeds from disposal of property and equipment	0
Purchases of marketable securities	10,398
Maturities and sales of marketable securities	9,799
Net cash (used in) provided by investing activities	-5,814
Proceeds from term loan	15,000
Proceeds from exercise of stock options	45
Issuance costs in connection with reverse recapitalization	-5,338
Cash acquired in connection with reverse recapitalization	-54,631
Proceeds from common stock issued in pipe financing, net of issuance costs	71,130
Net cash provided by financing activities	135,468
Effects of exchange rates on cash and cash equivalents	604
Net increase (decrease) in cash and cash equivalents	82,414
Cash and cash equivalents, beginning of year	12,118
Cash and cash equivalents, end of year	94,532

Unit: Thousand (K) dollars (except for numbers of shares and EPS).